SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Schantz PM, Moore AC, Muñoz JL, et al. Neurocysticercosis in an orthodox Jewish community in New York City. N Engl J Med 1992;327:6925.
  • 2
    Schantz PM. Cysticercosis in non-endemic countries: the example of the United States. In: GarciaHH, MartínezS, eds. Teniasis/cisticercosis por T. soliurn. Lima : Editorial Universo S.A., 1996;27786.
  • 3
    Preux PM, Melaku Z, Druet-Cabanac M, et al. Cysticercosis and neurocysticercosis in Africa: current status. Neurol Infect Epidemiol 1996;1:638.
  • 4
    Carpio A. Cisticercosis cerebral: enfermedad del subdesarrollo. Cuenca : Facultad de Ciencias Medicas de la Universidad de Cuenca, 1985.
  • 5
    Sarti E, Schantz PM, Plancaarte A, et al. Prevalence and risk factors for Taenia solium taeniasis and cysticercosis in humans and pigs in a village in Morelos, México. Am J Trop Med Hyg 1992;46:67785.
  • 6
    Carpio A, Santillán F, León P. Aspectos clinicos de la cisticercosis. Rev Inst Inv Cienc Salud (Ecuador) 1990;5:140.
  • 7
    McCormick GF, Zee CS, Heiden J. Cysticercosis cerebri. Arch Neurol 1982;39:5349.
  • 8
    Faust EC, Russell PF, Jung RC. Cysticercosis. In: FaustEC, ed. Clinical parasitology. Philadelphia : Lea & Febiger, 1979:52935.
  • 9
    Escobar A, Nieto D. Cysticercosis. In: MinklerJ, ed. The pathology of the nervous system. New York : McGraw-Hill, 1972:250715.
  • 10
    Evans C. The immunology of taeniasis/cysticercosis: implications for prevention and treatment. In: GarcíaHH, MartínezS, eds. Teniasis/cisticercosis por T. solium. Lima : Editorial Universo S.A., 1996:5064.
  • 11
    Flisser A, Willms K, Laclette JP, et al. Cysticercosis. Present state of knowledge and perspectives. New York : Academic Press, 1982.
  • 12
    Correa D, Dalma D, Espinoza B, et al. Heterogeneity of humoral immune components in human cysticercosis. J Parasitol 1985; 71:53541.
  • 13
    Goodman K, Carpio A, Ballagh SA. Case-control study of seropositivity for cysticercosis in Cuenca, Ecuador. J Neurol Sci 1997;150:S326.
  • 14
    Spina-Franca A, Livramento JA, Bacheschi LA, García-Lopez P. Cerebrospinal fluid immunoglobulins in cysticercosis of the central nervous system. Arq Neuropsiquiatr 1976;34:405.
  • 15
    Carpio A. Epidemiology of tropical neurology in South America. In: RoseFC, ed. Recent advances in tropical neurology. Amsterdam : Elsevier Sciences Publishers, 1995:3142.
  • 16
    Carpio A. La neurocisticercosis en el Ecuador. In: BenitezR, OrdoñezG, eds. Biopatología Andina y Tropical Ecuatoriana, Tomo III. Quito : Academia Ecuatoriana de Medicina, 1995:1383410.
  • 17
    García-Albea EE. Cisticercosis cerebral: Aportaciones al conocimiento de una enfermedad endémicu en España e Hispanoamérica. Madrid : Aran Ediciones S.A., 1991.
  • 18
    García-Ramos G, Rubio-Donnadieu F. Neurocysticercosis in the adult. In: PalaciosE, Rodriguéz-CarbajalJ, TaverasJM, eds. Cysticercosis of central nervous system. Springfield : Charles C Thomas, 1983:638.
  • 19
    Singhal BS, Ladiwala U. Neurocysticercosis in India. In: RoseFC, ed. Recent advances in tropical neurology. Amsterdam : Elsevier Sciences Publishers, 1995:3142.
  • 20
    Bittencourt PRM, Costa AJ, Oliveira TV, et al. Clinical, radio logical and cerebrospinal fluid presentation of neurocysticercosis: a prospective study. Arq Neuropsiquiatr (Sao Paulo) 1990;48:28695.
  • 21
    Bittencourt PRM, Adamolekun B, Bharucha N, et al. Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immuno-logic diagnosis, economics and therapy. Epilepsia 1996;37:11217.
  • 22
    Mervis B, Lotz JW. Computed tomography (CT) in parenchyma-tous cerebral cysticercosis. Clin Radiol 1980;31:5218.
  • 23
    Byrd SE, Locke GE, Biggers S, Percy AK. The computed tomography appearance of cerebral cysticercosis in adults and children. Radiology 1982;144:81923.
  • 24
    Enzman DR. Imaging of infections and inflammations of the central nervous system. New York Raven Press, 1984:10227.
  • 25
    Handler LC, Mervis B. Cerebral cysticercosis with reference to the natural history of parenchymal lesions. AJNR 1983;4:70912.
  • 26
    Rodriguéz-Carbajal J, Palacios G, Zeen Ch. Neuroradiology of the cysticercosis of the central nervous system. In: PalaciosJ, Rodriguéz CarbajalJ, TaverasJ, eds. Cysticercosis of the central nervous system. Springfield : Charles C. Thomas, 1983:10143.
  • 27
    Suss RA, Maravilla KR, Thompson J. MR imaging of intracranial cysticercosis: comparison with CT and anatomopathologic features. AJNR 1986;7:23542.
  • 28
    Martínez HR, Rangel-Guerra R, Elizondo G, et al. MR imaging in neurocysticercosis: a study of 56 cases. AJNR 1989;10:10119.
  • 29
    Carpio A, Placencia M, Santillán F, Escobar A. Proposal for a new classification of neurocysticercosis. Can J Neurol Sci 1994; 21:437.
  • 30
    Carpio A. Clasificación de la neurocisticercosis. In: GarcíaHH, MartínezS, eds. Teniasis/cisticercosis por T. solium. Lima : Editorial Universo S.A., 1996:13952.
  • 31
    Arriagada C, Matus C, Nogales-Gaete J. Tomografia computada en neurocisticercosis. In: ArriagadaC, Nogales-GaeteJ, AptW, eds. Neurocisticercosis. Aspectos Epidemiológicos, patológicos, inmunológicos, clínicos, imagenológicos y terapéuticos. San tiago – Chile : Anynog Ediciones, 1997:161207.
  • 32
    Paez R. Neuroimagen: texto de docencia medicu. Quito : Color-Offset, 1997.
  • 33
    Dumas JL, Visy JM, Belin C, Gaston A, Goldlust D, Dumas M. Parenchymal neurocysticercosis: follow-up and staging by MRI. Neuroradiology 1997;39:128.
  • 34
    Allan JC, Mencos F, García-Noval J, et al. Dipstick dot-ELISA for detection of Taenia coproantigens in humans. Parasitology 1993;107:7985.
  • 35
    Schenone H, Villarroel F, Rojas A, Ramirez R. Epidemiology of human cysticercosis in Latin America. In: FlisserA, WillmsK, LacletteJP, et al. Cysticercosis: present state of knowledge and perspectives. New York : Academic Press, 1982:2538.
  • 36
    Díaz F, García HH, Gilman RH, et al. Epidemiology of taeniasis and cysticercosis in a Peruvian village. Am J Epidemiol 1992; 135:87582.
  • 37
    Ramos-Kuri M, Montoya RM, Padilla A, et al. Immunodiagnosis of neurocysticercosis: disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients. Arch Neurol 199249:6336.
  • 38
    Palacios R, Alvarado M, Carpio A, Santillan F, Palacios M. Valoración de las técnicas immunológicas en el Diagnóstico de la cisticercosis cerebral. Rev Inst Inv Cienc Salud (Ecuador). 1988; 3:119.
  • 39
    Nieto D. Cysticercosis of the nervous system: diagnosis by means of the spinal fluid complement fixation. Neurology 1956;6:72538.
  • 40
    Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoproteins antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989; 159:509.
  • 41
    Tsang VC, Garcia HH. Immunoblot diagnostic test (EITB) for Taenia solium cysticercosis and its contribution to the definition of this under-recognized but serious public health problem. In: GarciaHH, MartínezS, eds. Teniasis/cisticercosis por T. solium. Lima : Editorial Universo S.A., 1996:25968.
  • 42
    Wilson M, Gryan R, Fried J, et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 1991;164:10079.
  • 43
    García HH, Martínez M, Gilman R, et al. Diagnosis of cysticercosis in endemic regions. Lancet 1991;338:54951.
  • 44
    García HH, Gilman R, Martínez M, Tsang VCW. Cysticercosis as a major cause of epilepsy in Peru. Lancet 1993;341:197200.
  • 45
    Moore AC, Lutwick LI, Schantz PM, et al. Seroprevalence of cysticercosis in an orthodox Jewish community. Am J Trop Med 1995;53:43942.
  • 46
    Cruz I. Epidemiologia de la neurocisticercosis en el Ecuador. In: GarciaHH, MartínezS, eds. Teniasis/cisticercosis por T. solium. Lima : Editorial Universo S.A., 1996:30311.
  • 47
    Palacio LG, Tobón M, Sanchez JL, Jiménes M, Jiménes I. Prevalencia de neurocisticercosis en individuos con epilepsia en Medellín, Colombia. In: GarciaHH, MartínezS, eds. Teniasis/cisticercosis por T. solium. Lima : Editorial Universo S.A., 1996: 291302.
  • 48
    Grill J, Rakotomalala W, Andriantsimahavandy A, et al. High prevalence of serological markers of cysticercosis among epileptic Malagasy children. Ann Trop Paediatr 1996; 16:18591.
  • 49
    García HH, Gilman RH, Tsang VC, Gonzalez AE. Clinical significance of neurocysticercosis in endemic villages: The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg 1997;91:1768.
  • 50
    Garcia-Noval J, Allan JC, Fletes C, et al. Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg 1996;55:2829.
  • 51
    Schantz PM, Sarti E, Plancarte A, et al. Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in México. Clin Infect Dis 1994; 18:87985.
  • 52
    García HH, Herrera G, Gilman RH, et al. Discrepancies between cerebral computed tomography and Western blot in the diagnosis of neurocysticercosis. Am J Trop Med Hyg 1994;50:1526.
  • 53
    Cruz ME, Davis A, Dixon H, Pawlowski ZS, Proaño J. Operational studies on the control of Taenia solium taeniasis/cysticercosis in Ecuador. Bull WHO 1989;67:4017.
  • 54
    Keilbach NM, de Aluja AS, Sarti-Gutierrez E. A program to control taeniasis-cysticercosis (T. solium): experiences in a Mexican village. Acta Leiden 1989;57:1819.
  • 55
    Diaz-Camacho SP, Candil-Ruiz A, Suate V, et al. Epidemiologic study and control of Taenia solium infections with praziquantel in a rural village of Mexico. Am J Trop Med Hyg 1991;45:52231.
  • 56
    Gilman RH, Garcia HH, Gonzales AE, et al. Métodos para controlar la transmisión de la cisticercosis. In: GarciaHH, MartínezS, eds. Teniasis/cisticercosis por T. solium. Lima : Editorial Universo S.A., 1996:32739.
  • 57
    Carpio A, Placencia M. Definition of contemporary surgical management in cistemal and parenchymatous cysticercosis cerebri. Neurosurgery 1992;30:9689.
  • 58
    Kramer LD, Locke GE, Byrd SE, Daryabagi J. Cerebral cysticercosis: documentation of natural history with CT. Radiology 1989; 171:45962.
  • 59
    Machddo LR, Nobrega JP, Barros NG, Livramento JA, Bacbeschi LA, Spina-Franca A. Computed tomography in neurocysticercosis: a 10-year long evolution analysis of 100 patients with an appraisal of a new classification. Arq Neuropsiquiatr (Sao Paulo) 1990;48:4148.
  • 60
    Martinez HR, Rangel-Guerra R, Arredondo-Estrada JH, Marfil A, Onofre J. Medical and surgical treatment in neurocysticercosis: a magnetic resonance study of 161 cases. J Neurol Sci 1995;130:2534.
  • 61
    Miller B, Grinnell V, Goldberg MA, et al. Spontaneous radio-graphic disappearance of cerebral cysticercosis: three cases. Neurology 1983;33:13779.
  • 62
    Cuetter AC, Garcia-Bobadilla J, Guerra LG, Martinez FM, Kaim B. Neurocysticercosis: focus on intraventricular disease. Clin Infect Dis 1997;24:15764.
  • 63
    Rajshekhar V. Etiology and management of single small CT lesions in patients with seizures: understanding a controversy. Acta Neurol Scand 1991;84:46570.
  • 64
    Rajshekhar V, Chandy MJ. Comparative study of CT and MRI in patients with seizures and a solitary cerebral cysticercus granuloma. Neuroradiology 1996;38:5426.
  • 65
    Rodiguez-Carbajal J, Salgado P, Gutierrez-Alvarado R, Escobar-Izquierdo A, Aruffo C, Palacios E. The acute encephalitic phase of neurocysticercosis: computed tomographic manifestations. AJNR 1983;4:515.
  • 66
    Zee CS, Segall HD, Destian S, Ahmadi J, Apuzzo MLJ. MRI of intraventricular cysticercosis: surgical implications. J Comput Assist Tomogr 1993; 17:9329.
  • 67
    Teitelbaum GP, Otto RJ, Watanabe AT, et al. MR imaging of neurocysticercosis. AJNR 1989;10:70918.
  • 68
    Mitchel WG, Snodgrass SR. Intraparenchymal cerebral cysticercosis in children: a benign prognosis. Pediatr Neurol 1985; 1:1516.
  • 69
    Mazer S, Antoniuk A, Ditzel LFS, Araujo JC. The computed tomographic spectrum of cerebral cysticercosis. Comput Radiol 1983;7:3738.
  • 70
    Lotz J, Hewlett R, Alheit B, Bowen R. Neurocysticercosis: correlative pathomorphology and MR imaging. Neuroradiology 1988;30:3541.
  • 71
    Arriagada V, Arriagada C, Terra E, Manen R, Julio D. Imagen de resonancia magnética en neurocisticercosis. In: ArriagadaC, No-gales-GaeteJ, AptW, eds. Neurocisticercosis: aspectos Epidemiológicos, patológicos, inmunológicos, clínicos, imagenológicos y terapéuticos. Santiago , Chile : Arrynog Ediciones, 1997: 20978.
  • 72
    Escobar A. The pathology of neurocysticercosis. In: PalaciosE, Rodriguez-CarbajalJ, TaverasJM, eds. Cysticercosis of central nervous system. Springfield : Charles C Thomas, 1983:2754.
  • 73
    Trelles JO, Trelles L. Cysticercosis of the nervous system. In: VinkenPJ, BruynGW, eds. Handbook of clinical neurology. Amsterdam : North-Holland, 1978:291320.
  • 74
    Wadia NS, Desai S, Bhatt M. Disseminated cysticercosis: new observations, including CT scan findings and experience with treatment by praziquantel. Brain 1988;111:507614.
  • 75
    Mitchel WG, Crawford TO. Intraparenchymak cerebral cysticercosis in children: diagnosis and treatment. Pediatrics 1988;82:7682.
  • 76
    Rodriguéz-Carbajal J, Placencia M, Carpio A. Calcificaciones intracraneales anormales: 135 casos estudiados por T.A.C. Neurol Neurocir Psiquiatr 1983;24:4960.
  • 77
    Sotelo J, Guerrero J, Rubio F. A new classification based on active and inactive forms. Arch Intern Med 1988;148:4425.
  • 78
    Stepien L. Cerebral cysticercosis in Poland: clinical symptoms and operative results in 132 cases. J Neurosurg 1962;19:50513.
  • 79
    Rangel R, Torres B, Del Brutto O, et al. Cysticercotic encephalitis: a severe form in young females. Am J Trop Med Hyg 1987; 36:38792.
  • 80
    Noboa C. Encefalitis cisticercosa: análisis de 10 casos. Rev Ecuat Neurol 1992;1:6171.
  • 81
    López-Hernández A, Garaizar C. Manifestations of infantile cerebral cysticercosis. In: PalaciosE, Rodriguez-CarbajalJ, TaverasJM, eds. Cysticercosis of central nervous system. Springfield : Charles C Thomas, 1983;6983.
  • 82
    Madrazo I, García-Renteria JA, Sandoval M, Lopez-Vega FJ. Intraventricular cysticercosis. Neurosurgery 1983;12:14852.
  • 83
    Salazar A, Sotelo J, Martínez H, Escobedo F. Differential diagnosis between ventriculitis and fourth ventricle cyst in neurocysticercosis. J Neurosurg 1983;59:6603.
  • 84
    Apuzzo MLJ, Dobkin WR, Zee C-S, et al. Surgical considerations in treatment of intraventricular cysticercosis: an analysis of 45 cases. J Neurosurg 1984;60:4007.
  • 85
    Kioumehr F, Dadsetan MR, Feldman N, et al. Postcontrast MRI of cranial meninges: leptomeningitis versus pachymeningitis. J Comput Assist Tomogr 1995;19:71320.
  • 86
    Alarcón F, Hidalgo F, Moncayo J, Viñán I, Dueñas G. Cerebral cysticercosis and stroke. Stroke 1992;23:2248.
  • 87
    Alarcón F, Vanormeligen K, Moncayo J, Viñán I. Cerebral cysticercosis as a risk factor for stroke in young and middle-aged people. Stroke 1992;23:15635.
  • 88
    Cantú C, Barinagarrementeria F. Cerebrovascular complications of neurocysticercosis: clinical and neuroimaging spectrum. Arch Neurol 1996;53:2339.
  • 89
    Barinagarrementeria F, Cantú C. Arteritis cerebral cisticercosa. In: ArriagadaC, Nogales-Gaete AptW, eds. Neurocisticercosis: aspectos epidemiológicos, patológicos, inmunológicos. Clínicos, imagenológicos y terapéuticos. Santiago – Chile : Arrynog Ediciones, 1997:13952.
  • 90
    Carpio A, Ochoa M, Bustamante J, et al. Meningitis crónica: estudio clínico de 47 casos. Rev Inst Inv Cienc Salud (Ecuador) 1987;2:519.
  • 91
    Lopez-Albo W. Cisticercosis del neuro-eje y de las meninges. An Med Int (Madrid) 1932;1:84978.
  • 92
    MacArthur WP. Cysticercosis as a cause of epilepsy in man. Trans R Soc Med Hyg 1933;26:5258.
  • 93
    MacArthur WP. Cysticercosis seen in the British Army with special reference to the production of epilepsy. Trans R Soc Med Hyg 1934;27:34363.
  • 94
    Stepien L, Chorobski J. Cysticercosis cerebri and its operative treatment. Arch Neurol Psychiatry 1949;61:499527.
  • 95
    Dixon HBF, Hargreaves WH. Cysticercosis (T. solium): a further 10 years study covering 284 cases. Q J Med 1944; 13:10721.
  • 96
    Dixon HBF, Lipscomb FM. Cysticercosis: an analysis and follow-up of 450 cases. Med Res Council. Spec.rep. no. 299. London : Her Majesty's Stationery Office, 1961:158.
  • 97
    Lombardo L, Mateos JH. Cerebral cysticercosis in Mexico. Neurology 1961;11:8248.
  • 98
    Lopez-Albo W. Aspectos clinicos de la cisticercosis del sistema nervioso central. Mexico : Multa Pavcis Médica, 1945.
  • 99
    Escobar A. Cisticercosis cerebral: estudio de 20 casos. Arch Mex Neurol Psiquiatr 1952;14567.
  • 100
    Bittencourt PRM, Gracia CM, Lorenzana P. Epilepsy and parasitosis of the central nervous system. Recent adv epilepsy. 1988; 4:12359.
  • 101
    Montenegro R, Placencia M, Paredes V, et al. Síndromes cerebrovasculares asociados a cisticercosis cerebral. Rev Ecuat Neurol 1993;2:104.
  • 102
    Alarcón T, Olivares L. Cisticercosis cerebral: manifestaciones clínicas en un medio de alta prevalencia. Rev Invest Clin 1975; 27:20915.
  • 103
    Otero E, Cordova S, Diaz F, García-Teruel I, Del Brutto OH. Acquired epileptic aphasia (the Landau-Kleffner syndrome) due to neurocysticercosis. Epilepsia 1989;30:56972.
  • 104
    Shandera WX, White AC, Chen AC, Diaz P, Armstrong R. Neurocysticercosis in Houston, Texas. Medicine 1994;73:3752.
  • 105
    Bittencourt PRM, Adamolekun B, Bharucha N, et al. Epilepsy in the tropics: I. Epidemiology, socioeconomic risk factors, and etiology. Epilepsia 1996;37:11217.
  • 106
    Chinchilla N, De Andres C, Roldan SG. Frecuencia de neurocisticercosis en un hospital de Madrid. Arch de Neurobiol 1989;52:28794.
  • 107
    Earnest MP, Reller LB, Filley CM, Grk AJ. Neurocysticercosis in the United States: 35 cases and a review. Rev Infect Dis 1987;9:96176.
  • 108
    Martínez SM. Controversias clínicas y terapeúticas en neurocisticercosis. In: GarciaHH, MartínezSM, eds. Teniasis/cisticercosis por T. solium. Lima : Editorial Universo S.A., 1996:20716.
  • 109
    Obrador S. Cysticercosis cerebri. Acta Neurochir 1972;3:32064.
  • 110
    Stepien L. Cerebral cysticercosis in Poland: clinical symptoms and operative results in 132 cases. J Neurosurg 1962;19:50513.
  • 111
    Placencia M, Paredes V, Franco J, et al. Clinical profile of 182 patients with epileptic seizures associated with brain cysticercosis. Epilepsia 1991;32:1089.
  • 112
    Richards FO Jr, Schantz PM, Ruiz-Tiben E, Sorvillo FJ. Cysticercosis in Los Angeles County. JAMA 1985;254:34448.
  • 113
    Scharf D. Neurocysticercosis: two hundred thirty-eight cases from a California hospital. Arch Neurol 1988;45:77780.
  • 114
    Monteiro L, Almeida-Pinto J, Stocker A, Sampaio-Silva M. Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients. J Neurol 1993;241:1521.
  • 115
    Monteiro L, Nunes B, Mendonaca D, Lopes J. Spectrum of epilepsy in neurocysticercosis: a long-term follow-up of 143 patients. Acta Neurol Scand 1995;92:1, 33–40.
  • 116
    Forlenza OV, Filho AH, Nobrega JP, et al. Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil. J Neurol Neurosurg Psychiatry 1997;62:6126.
  • 117
    Placencia M, Paredes V, Madera A, Arroyo R, Franco J. La cisticercosis cerebral en epidemiología de epilepsia. Vademecun Farmacéutico, Tercera Edición, Quito : Edifarma, 1993.
  • 118
    Nogales-Gaete J, Arriagada C, Gonzáles J. Sindromes anatomo-clínicos de la neurocisticercosis. In: ArriagadaC, Nogales-Gaete, AptW, eds. Neurocisticercosis: aspectos epidemiológicos, patológicus, inmunológicos, clínicos, imagenológicos y terapéuticos. Santiago – Chile : Arrynog Ediciones, 1997:11738.
  • 119
    Estañol B, Corona T, Abad P. A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol Neurosurg Psychiatry 1986;49:11314.
  • 120
    Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990;150:32532.
  • 121
    Vázquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327:696701.
  • 122
    Del Brutto OH, Santibañez R, Noboa CA, Aguirre R, Diaz E, Alarcón TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992;42:38992.
  • 123
    Hauser WA, Hesdorffer DH. Epilepsy: frequency, causes and consequences. New York : Demos Press, 1990.
  • 124
    Commission on Epidemiology and Prognosis of the International League Against Epilepsy. Guidelines for epidemiological studies on epilepsy. Epilepsia 1993;34:5926.
  • 125
    Commission on Epidemiology and Prognosis of the International League Against Epilepsy. The epidemiology of the epilepsies: future directions. Epilepsia 1997;38:6148.
  • 126
    Hauser WA. Recent developments in the epidemiology of epilepsy. Acta Neurol Scand 1995;162:1721.
  • 127
    Sander JWAS, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry 1996;61:43343.
  • 128
    Carpio A, Hauser WA. The distribution and etiology of epilepsy in the tropics of America. Rev Ecuat Neurol 1993;2:13745.
  • 129
    Adamolekun A, Carpio A, Carvalho-Filho F, et al. Relationship between epilepsy and tropical diseases. Epilepsia 1994;35:8993.
  • 130
    Arruda WO. Etiology of epilepsy: a prospective study of 200 cases. Arq Neuropsiquiatr 1991;49:2514.
  • 131
    Bending J, Catford J. Epidemic of bums in New Guinea due to cerebral cysticercosis. Lancet 1983;330:922.
  • 132
    Gadjusek DC. Introduction of T. solium in West New Guinea with a note on an epidemic of bums from cysticercus epilepsy in the Ekari people of the Wissel Lakes area. PNG Med J 1978;21:239.
  • 133
    Ahuja GK, Mohanta A. Late onset epilepsy. Acta Neurol Scand 1982;66:21626.
  • 134
    Sethi PK, Kuar BR, Madan VS, Mohan V. Appearing and disappearing CT scan abnormalities and seizures. J Neurol Neurosurg Psychiatry 1985;48:8669.
  • 135
    Bhatia S, Tandon PN. Solitary “microlesions” in CT: a clinical study and follow-up. Neurol India 1988;36:13950.
  • 136
    Bansal BC, Dua A, Gupta R, Gupta MS. Appearing and disappearing CT scan abnormalities in epilepsy in India: an enigma. J Neurol Neurosurg Psychiatry 1989;52:11857.
  • 137
    Wadia RS, Makhale CN, Kelkar AN, Grant KB. Focal epilepsy in India with special reference to lesions showing ring or disc like enhancement on contrast computed tomography. J Neurol Neurosurg Psychiatry 1987;50:1298301.
  • 138
    Rajshekhar V, Chacko G, Haran RP, Chandy MJ, Chandi SM. Clinicoradiological and pathological correlations in patients with solitary cysticercus granuloma and epilepsy: focus on presence of the parasite and oedema formation. J Neurol Neurosurg Psychiatry 1995;59:2846.
  • 139
    Wani MA, Benerji AK, Tandom PN, Bhargava S. Neurocysticercosis: some uncommon presentations. Neurol India 1981;29:5863.
  • 140
    Tandom PM, Bhargava S. CNS tuberculosis: lessons learnt from CT studies. Neurol India 1980;28:20712.
  • 141
    Basauri L, Zuleta A, Loayza P, Olivares A. Microabscesses and presumptive inflammatory nodules of the brain. Acta Neurochir 1983;68:2732.
  • 142
    Michael AS, Levy JM, Paige ML. Cysticercosis mimicking brain neoplasm. J Comput Assist Tomogr 1990;14:70811.
  • 143
    Jayakumar PN, Taly AB, Mohan PK. Transient computerized tomographic (CT) abnormalities following partial seizures. Acta Neurol Scand 1985;72:269.
  • 144
    De Beyl DZ, Hermanus N, Cille H, Goldman S. Focal seizures with reversible hypodensity in the CT scan. J Neurol Neurosurg Psychiatry 1985;48:187.
  • 145
    Chandy MJ, Rajshekhar V, Ghosh S, et al. Single small enhancing CT lesions in India patient with epilepsy: clinical, radiological and pathological considerations. J Neurol Neurosurg Psychiatry 1991;54:7025.
  • 146
    Rajshekhar V, Chandy MJ. Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures. Acta Neurol Scand 1997;96:7681.
  • 147
    Ahuja GK, Behari M, Goulatia RK, Jailkhani BL. Disappearing CT lesions in epilepsy: is tuberculosis or cysticercosis the cause Neurol Neurosurg Psychiatry 1989;529156.
  • 148
    Rawlings D, Ferreiro DM, Messing RO. Early CT reevaluation after empiric praziquantel therapy in neurocysticercosis. Neurology 1989;39:73941.
  • 149
    Del Brutto OH. The use of albendazole in patients with single lesions enhanced on contrast CT. N Engl J Med 1993;328:3567.
  • 150
    Rajshekhar V. Albendazole therapy for persistent solitary cysticercus granulomas in patient with seizures. Neurology 1993;43: 123840.
  • 151
    Padma MV, Behari M, Misra NK, Ahuja NK. Albendazole in single CT ring lesions in epilepsy. Neurology 1994;44:13446.
  • 152
    Hitchcock ER. Cysticercosis in the UK. J Neurol Neurosurg Psychiatry 1985;50:10802.
  • 153
    Case records of the Massachusetts General Hospital. Case 20, 1990. N Engl J Med 1990;322:144658.
  • 154
    Case records of the Massachusetts General Hospital. Case 26, 1994. N Engl J Med 1994;330:18893.
  • 155
    Carpio A. Efecto del tratamiento antiparasitario en la epilepsia secundaria a neurocisticercosis. In: GarciaHH, MartínezS, eds. Teniasis/cisticercosis por T. solium. Lima : Editorial Universo S.A., 1996:193206.
  • 156
    Carpio A, Santillán F, León P, Flores C, Hauser WA. Is the course of neurocysticercosis modified by treatment with antihelminthic agents Arch Intern Med 1995;155:19828.
  • 157
    Kar AM, Garg RK. Management of small solitary enhancing (ring or disc) CT lesion in patients with epilepsy: does it need change in strategy Adv Clin Neurosci 1995;5:30310.
  • 158
    Garg RK. Childhood neurocysticercosis: issues in diagnosis and management. Indian Pediatr 1995;32:10239.
  • 159
    Garg RK, Agrawal A, Medical treatment for cysticercosis. Arch Neurol 1996;53:295.
  • 160
    Kramer LD. Medical treatment of cysticercosis: ineffective. Arch Neurol 1995;52:1012.
  • 161
    Kramer LD. Antihelminthic therapy for neurocysticercosis. Arch Neurol 1990;47:105960.
  • 162
    Salazar M, Gonzáles D. Ensayo terapeútico de la cisticercosis con metrifonato. Rev Inst Salud Pública (Méx) 1972;32:1.
  • 163
    Velasco-Suárez M. Medical treatment of neurocysticercosis. In: PalaciosE, Rodriguez-CarbajalJ, TaverasJM, eds. Cysticercosis of central nervous system. Springfield , IL Charles C Thomas, 1983:14954.
  • 164
    Tellez-Giron E, Ramos MC, Montante M. The effect of fluobendazole against cysticercus cellulosae in pig. San Luis Potosi : University of San Luis, Department of Biochemistry, 1980.
  • 165
    Robles C, Chavarria M. Presentación de un caso clínico de cis ticercosis cerebral tratado médicamente con un nuevo fármaco: praziquantel. Salud Pública Mex 1979;21:60318.
  • 166
    Xiao ZX, Zhao CY, Liu LP. Albendazole treatment in cerebral cysticercosis. Chin J Int Med 1986;25:1002.
  • 167
    Alarcón F, Escalante L, Dueñas G, et al. Neurocysticercosis: short course of treatment with albendazole. Arch Neurol 1989;46:12316.
  • 168
    Escobedo F, Penagos P, Rodriguéz J, Sotelo J. Albendazole therapy for neurocysticercosis. Arch Intern Med 1987;147:73841.
  • 169
    Sotelo J, Escohedo F, Rodriguéz-Carbajal J, Torres B, Rubio-Donnadieu F. Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med 1984;310:10017.
  • 170
    Takayanagui OM, Jardim E. Therapy for neurocysticercosis: comparison between albendazole and praziquantel. Arch Neurol 1992;49:2904.
  • 171
    van Dellen JR, McKeown CP. Praziquantel in active cerebral cysticercosis. Neurosurgery 1988;22:925.
  • 172
    Botero D, Tanowitz HB, Weiss LM, Wittner M. Taeniasis and cysticercosis. Parasit Dis 1993;7:68397.
  • 173
    Cruz M, Cruz I, Horton J. Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation. Trans R Soc Trop Med Hyg 1991;85:2447.
  • 174
    Robles C, Sedano AM, Vargas-Tentori N, Galindo-Virgen S. Long-term results of praziquantel therapy in neurocysticercosis. J Neurosurg 1987;66:35963.
  • 175
    Proano JV, Madrazo I, Garcia L, Garcia E, Corea D. Albendazol and praziquantel treatment in neurocysticercosis of the fourth ventricle. J Neurosurg 1997;87:2933.
  • 176
    Garcia HH, Gilman RH, Horton J, et al. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment: Cysticercosis Working Group in Peru. Neurology 1997;48:14217.
  • 177
    Salinas R, Gamer P. Neurocysticercosis. Arch Neurol 1996;53:213.
  • 178
    García HH, Gilman R. Medical treatment of cysticercosis: ineffective vs. effective. Arch Neurol 1996;52:941.
  • 179
    Garg RK, Kar AM, Jain S. Failure of albendazole therapy in two common types of parenchymal neurocysticercosis. J Assoc Physicians India 1995;43:7067.
  • 180
    Hachinski VC, Medical treatment of cysticercosis. Arch Neurol 1995;52:104.
  • 181
    Moodley M, Moosa A. Treatment of neurocysticercosis; is praziquantel the new hope Lancet 1989;1:2623.
  • 182
    White AC. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 1997;24:10115.
  • 183
    Caplan LR, Estanol B, Mitchel WG, Loyo-Varela M. How to manage patients with neurocysticercosis. Eur Neurol 1997;37:12431.
  • 184
    Loyo-Varela M. How to manage patients with neurocysticercosis: surgical treatment of cerebral cysticercosis. Eur Neurol 1997;37:12930.
  • 185
    Estanol B. How to manage patients with neurocysticercosis: medical treatment of cerebral cysticercosis. Eur Neurol 1997;37:1256.
  • 186
    Medina MT, Genton P, Montoya MC, et al. Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticerco sis: a pilot trial. Epilepsia 1993;34:10247.
  • 187
    Del Brutto OH. Prognostic factors for seizures recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 1994;44:17069.
  • 188
    Rolfs A, Mühlschlegel F, Jansen-Rosseck R, et al. Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. Neurology 1995;45:5328.
  • 189
    Manreza ML. Neurocysticercosis in children. In: FejermanN, ChamolesNAN, eds. Trends in pediatric neurology. Amsterdam : Elsevier Science Publishers B.V, 1993:2958.
  • 190
    Antoniuk SA, Bruck I, Wittig E; Accorsi A. Neurocisticercose na infancia. Arq Neuropsiquiatr (Sao Paulo) 1991;49:4751.
  • 191
    Rosenfeld EA, Byrd SE, Shulman ST. Neurocysticercosis among children in Chicago. Clin Infect Dis 1996;23:2628.
  • 192
    Annerges JF, Hauser WA, Elveback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia 1979;20:72937.
  • 193
    Hauser WA, Anderson E, Loewenson RB, McRoberts SM. Seizure recurrence after a first unprovoked seizure. N Engl J Med 1982;307:5228.
  • 194
    Elwes RDC, Johson AL, Shorvon SD, Reynolds EH. The prognosis for seizure disorders in newly diagnosed epilepsy. N Engl J Med 1984;311:9447.
  • 195
    Hauser WA, Rich SS, Annerges JF, Anderson VF. Seizure recurrence after a first unprovoked seizure: an extended follow-up. Neurology 1990;40116370.
  • 196
    Shinnar S, Berg AT, Moshé SL, et al. Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study. Pediatrics 1990;85:107685.
  • 197
    Cockerell OC, Johnson AL, Sander JWAS, Shorvon SD. Prognosis of epilepsy: a review and further analysis of the first nine years of British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia 1997;38:4755.
  • 198
    Shinnar S, Vining EP, Mellitis ED, et al. Discontinuing antiepileptic medication in children with epilepsy after two years with out seizures: a prospective study. N Engl J Med 1985;313:97680.
  • 199
    Berg AT, Shinnar S. Relapse following discontinuation of anti-epileptic drugs: a meta-analysis. Neurology 1994;44:6018.
  • 200
    Gracia FJ, Loo S, Castillo Luis, et al. Epidemiology of epilepsy in Guaymi Indians from Bocas del Toro province, Republic of Panama. Epilepsia 1990;31:71823.
  • 201
    Mitchel WG. How to manage patients with neurocysticercosis: pediatric neurocysticercosis in North America. Eur Neurol 1997;37:1269.